Expand LRMR Menu
LRMR MENU

LRMR Latest Press Releases

-- March 4, 2026 --

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March Globe Newswire 4:05 PM

-- February 25, 2026 --

Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering Globe Newswire 8:59 PM
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering Globe Newswire 4:03 PM

-- February 24, 2026 --

Biotech and Big Tech Drive the Morning Narrative Globe Newswire 10:17 AM
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026 Globe Newswire 7:00 AM

-- December 18, 2025 --

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- November 5, 2025 --

Larimar Therapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:00 AM

-- October 30, 2025 --

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - LRMR Business Wire 6:00 PM

-- October 29, 2025 --

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 12:10 PM

-- October 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:00 AM

-- October 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:09 AM

-- October 22, 2025 --

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - LRMR Business Wire 12:16 PM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:01 AM

-- October 16, 2025 --

Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR PRNewswire 4:44 AM

-- October 15, 2025 --

Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR Business Wire 9:30 PM
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 9:09 PM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 1:50 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 4:37 PM
Market Data Delayed 15 Minutes